Why the study?
Are eNOS and ACE gene polymorphisms associated with in-stent restenosis in patients receiving bare metal or drug-eluting stents?
Are eNOS and ACE gene polymorphisms associated with in-stent restenosis in patients receiving bare metal or drug-eluting stents?
The eNOS gene polymorphism (GA and AA genotypes), along with hypertension and stent length, are independent predictors of in-stent restenosis after BMS or DES implantation in an Egyptian population.
Answers are grounded in this paper and cite their sources.
Identifies eNOS variants as potential risk markers for in-stent restenosis;.
= 102) who received a DES. eNOS and ACE genes polymorphism were analyzed by polymerase chain reaction (PCR). We found that the GA and AA genotypes of the eNOS gene were associated with the ISR with both BMS and DES. However, the ACE gene was not associated with ISR. We concluded that eNOS gene polymorphism is associated with ISR. Hypertension, stent length, and AA genotype of the eNOS gene were found to be independent predictors of the occurrence of ISR after both BMS and DES use.
No takes yet. Share an insight, caveat, or question.
El-Aziz et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: